Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of SA-001 in Pancreatic Exocrine Insufficiency
NCT00401076Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2008
- Primary completion
- Sep 2010
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of LipaCreon in pancreatic exocrine insufficiency (EPI), sponsored by Abbott Laboratories. Started Jul 2008; status: completed.
02
Drugs
LipaCreon
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT00401076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401076.